<DOC>
	<DOC>NCT00245947</DOC>
	<brief_summary>Evaluate the response of inflammatory serum markers to oral ERB-041 in subjects with inflammation associated with active Crohn's disease.</brief_summary>
	<brief_title>Study Evaluating ERB-041 in Active Crohn's Disease</brief_title>
	<detailed_description />
	<mesh_term>Crohn Disease</mesh_term>
	<criteria>Men and women, minimum 18 years of age with a diagnosis of Crohn's disease greater than 3 months, Eligible subjects must have adequate hematologic, renal, and hepatic function. Other inclusions apply Use of the following medications within the specified time period before randomization is prohibited: Within 48 hours before randomization Nonsteroidal antiinflammatory drugs (NSAIDs) Within 2 weeks before randomization Herbal supplements (except for a daily multivitamin/mineral supplement not containing herbal components). Other exclusions applies</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Crohn's Disease</keyword>
	<keyword>Inflammation</keyword>
</DOC>